Study of an Anti-TLR4 mAb in Rheumatoid Arthritis
Clinical trial NCT03241108 · COMPLETED
Trial details
- NCT number
- NCT03241108
- Sponsor
- Light Chain Bioscience - Novimmune SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2018-06-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.